Sarepta Therapeutics saw the highest growth of 2.49% in patent filings in May and 0.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Sarepta Therapeutics‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Sarepta Therapeutics has been focused on protecting inventions in Japan(JP) with five publications in Q2 2024
The Japan(JP) Patent Office dominates the patent filings and grants with nearly 24% filings and 10% grants. The Japan(JP), World Intellectual Property Organization(WIPO), China(CN), and Denmark(DK) patent Office are among the top ten patent offices where Sarepta Therapeutics is filings its patents. Among the top granted patent authorities, Sarepta Therapeutics has 10% of its grants in Japan(JP), 10% in China(CN) and 10% in European Patent Office(EPO).
Roche and Ionis Pharmaceuticals could be the strongest competitors for Sarepta Therapeutics
In terms of grant share, Sarepta Therapeutics stands in seventh position among its competitors. Roche and Ionis Pharmaceuticals secured the top positions according to recent patent publication data.
Patents related to rare diseases and climate change lead Sarepta Therapeutics's portfolio
Sarepta Therapeutics has the highest number of patents in rare diseases followed by, climate change. For rare diseases, nearly 78% of patents were filed and 67% of patents were granted in Q2 2024.
Muscular dystrophy related patents lead Sarepta Therapeutics portfolio followed by bacterial infections, and viral infections
Sarepta Therapeutics has highest number of patents in muscular dystrophy followed by bacterial infections, viral infections, duchenne muscular dystrophy, and amyotrophic lateral sclerosis. For muscular dystrophy, nearly 30% of patents were filed and 71% of patents were granted in Q2 2024.
For comprehensive analysis of Sarepta Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
